- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01335152
Online Stress Management and Coping Skills Training for Women With Breast Cancer
Coping With Breast Cancer and Treatment: An E-Learning Course for Skills and Strategies
Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer.
This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support.
The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer.
This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support.
The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98122
- Talaria, Inc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of stage 0, I, II or III breast cancer within past 18 months
- Elevated stress, distress or negative mood
- Access at least 1.5 - 2 hours per week to a computer with audio capabilities that is connected to the internet
- Ability to read, write, and speak English at a sixth grade level
- Access to a telephone and an active e-mail account
Exclusion Criteria:
- Cancer diagnosis is a recurrence
- Diagnosis of schizophrenia
- Use of anti-psychotic medication
- Diagnosis of bipolar disorder without use of mood stabilizing medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Web-based workbook
Participants will use one chapter of the web-based workbook each week for 10 weeks.
The workbook consists of stress management education, cognitive behavioral interventions and relaxation training exercises.
|
10 chapter web-based workbook that teaches stress management, cognitive behavioral coping skills and relaxation training.
Other Names:
|
No Intervention: Waitlist control group
Participants will no intervention for the first 10 weeks of the study and then will receive the web-based intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PHQ GAD-7 - Anxiety
Time Frame: baseline, post-intervention, follow-up
|
7-item self-report questionnaire measureing anxiety.
|
baseline, post-intervention, follow-up
|
CES-D 10
Time Frame: baseline, post-intervention, follow-up
|
10 item self-report measure of depression.
|
baseline, post-intervention, follow-up
|
FACT-B: Functional Assessment of Cancer Therapy - Breast
Time Frame: baseline, post-intervention, follow-up
|
44 item self-report measure of health related quality of life for breast cancer patients.
|
baseline, post-intervention, follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Revised Impact of Event Scale
Time Frame: baseline, post-intervention, follow-up
|
22 item self-report measure of intrusive thoughts and avoidance of cancer-related thoughts.
|
baseline, post-intervention, follow-up
|
Benefit Finding Scale for breast cancer
Time Frame: baseline, post-intervention, follow-up
|
17-item self-report measure of finding positive impact of negative events.
|
baseline, post-intervention, follow-up
|
CANCER BEHAVIOR INVENTORY (CBI-B)
Time Frame: baseline, post-intervention, follow-up
|
16-item self-report measure of self-efficacy for coping with cancer and cancer treatment.
|
baseline, post-intervention, follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kelly M Carpenter, PhD, Talaria, Inc
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CA106154
- 5R44CA106154-03 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
Clinical Trials on Coping with Breast Cancer web-based workbook
-
Stanford UniversityUniversity of California, BerkeleyCompletedDepression | Breast Cancer | Stress Disorders, Post-traumaticUnited States
-
Stanford UniversityUniversity of California, BerkeleyCompletedDepression | Breast Cancer | Stress Disorders, Post-TraumaticUnited States
-
ISA Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI)UnknownStress | Sleep DisordersUnited States
-
Alanya Alaaddin Keykubat UniversityRecruitingCervical Cancer | Cancer FearTurkey
-
Children's Mercy Hospital Kansas CityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Idiopathic ArthritisUnited States
-
Istanbul University - Cerrahpasa (IUC)Recruiting
-
University Hospital, BordeauxSRIOP 2016, SIRIC BRIOCompleted
-
Sakarya UniversityRecruiting
-
Stanford UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Southern... and other collaboratorsRecruitingAlcohol Drinking | Alcohol Use Disorder | Alcohol Abuse | Military Family | Relations, InterpersonalUnited States
-
University of Texas at AustinWashington University School of Medicine; Ohio State UniversityCompletedStage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Ductal Carcinoma in Situ | Lobular Breast Carcinoma | Stage III Breast Cancer | Ductal Breast CarcinomaUnited States